News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,837 Results
Type
Article (5019)
Company Profile (18)
Press Release (219800)
Section
Business (82216)
Career Advice (461)
Deals (15052)
Drug Delivery (8)
Drug Development (19096)
Employer Resources (30)
FDA (3677)
Job Trends (3901)
News (120147)
Policy (7505)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14765)
ALS (19)
Alzheimer's disease (246)
Antibody-drug conjugate (ADC) (12)
Approvals (3693)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (11)
Biotechnology (22)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (425)
Cardiovascular disease (21)
Career advice (391)
Career pathing (2)
CAR-T (30)
Cell therapy (101)
Cervical cancer (2)
Clinical research (16024)
Collaboration (162)
Compensation (151)
Complete response letters (2)
COVID-19 (305)
CRISPR (7)
C-suite (91)
Cystic fibrosis (16)
Data (490)
Depression (5)
Diabetes (38)
Diagnostics (2036)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40734)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37689)
Executive appointments (287)
FDA (3913)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (174)
Gene editing (15)
Generative AI (2)
Gene therapy (46)
GLP-1 (106)
Government (408)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (320)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (4)
Legal (2330)
Liver cancer (17)
Lung cancer (50)
Lymphoma (27)
Management (10)
Manufacturing (45)
MASH (27)
Medical device (3856)
Medtech (3857)
Mergers & acquisitions (7417)
Metabolic disorders (113)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (336)
NextGen: Class of 2025 (1675)
Non-profit (727)
Northern California (876)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (18)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24527)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4780)
Phase II (6961)
Phase III (5551)
Pipeline (526)
Policy (4)
Postmarket research (625)
Preclinical (1864)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (64)
Real estate (1874)
Recruiting (8)
Regulatory (5106)
Reports (14)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (671)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (11)
United States (6709)
Vaccines (35)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (25)
Last 7 days (215)
Last 30 days (869)
Last 365 days (10256)
2025 (2557)
2024 (11032)
2023 (13198)
2022 (18667)
2021 (19709)
2020 (18265)
2019 (13217)
2018 (10208)
2017 (10001)
2016 (9158)
2015 (12119)
2014 (9588)
2013 (7709)
2012 (8329)
2011 (8796)
2010 (8636)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11436)
Australia (1603)
California (1831)
Canada (667)
China (68)
Colorado (78)
Connecticut (91)
Delaware (28)
Europe (24438)
Florida (258)
Georgia (33)
Idaho (23)
Illinois (110)
India (6)
Indiana (60)
Iowa (1)
Japan (64)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (39)
Maryland (214)
Massachusetts (1477)
Michigan (84)
Minnesota (135)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (18)
New Jersey (537)
New Mexico (5)
New York (455)
North Carolina (316)
North Dakota (2)
Northern California (876)
Ohio (54)
Oklahoma (5)
Oregon (3)
Pennsylvania (332)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (671)
Tennessee (35)
Texas (215)
Utah (57)
Virginia (41)
Washington D.C. (8)
Washington State (161)
West Virginia (2)
Wisconsin (20)
224,837 Results for "bioxcel corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
March 28, 2025
·
17 min read
Press Releases
BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering
March 5, 2025
·
5 min read
Press Releases
BioXcel Therapeutics Announces Reverse Stock Split
February 6, 2025
·
6 min read
Press Releases
BioXcel Therapeutics Provides Clinical and Business Update
February 5, 2025
·
12 min read
Press Releases
BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
March 10, 2025
·
12 min read
Press Releases
BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
March 12, 2025
·
10 min read
Press Releases
BioXcel Therapeutics Announces FDA Closed its Inspection of Site for Phase 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimer’s Dementia
March 4, 2025
·
7 min read
Press Releases
BioXcel Therapeutics to Present at ThinkEquity Conference
October 29, 2024
·
5 min read
Pharm Country
BioXcel Therapeutics to Present at Jefferies 2024 Global Healthcare Conference
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, announced that CEO Vimal Mehta, Ph.D., will present at the Jefferies Global Healthcare Conference in New York City.
May 28, 2024
·
9 min read
Business
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, announced its financial results for the first quarter of 2024.
May 9, 2024
·
16 min read
1 of 22,484
Next
